24 February 2021 2 Min Read
DRUGMAKER
Adcock Ingram to shift product mix to protect its profit margins
Changes in consumer behaviour continue to put pressure on the group, but it has proceeded with an interim dividend and is looking to grow
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In